Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Equine Natriuretic Peptides A (NPPA), N-His

Cat. No.AP1C2

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Equine Natriuretic Peptides A (NPPA), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 13.8 kDa. The purity is>95% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Equine
Expression System E.coli
Purity >95% (SDS-PAGE)
Predicted Molecular Weight 13.8 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.

Target Information

Equine natriuretic peptides A (NPPA) is a hormone primarily produced in the atria of the heart, playing a crucial role in regulating blood pressure and fluid balance in horses. It promotes vasodilation, increases sodium excretion, and inhibits the renin-angiotensin-aldosterone system, which helps reduce blood volume and pressure. NPPA is also involved in cardiac remodeling and can serve as a biomarker for heart conditions, indicating the heart's response to stress and volume overload.

Protein Equine Natriuretic Peptides A (NPPA)
Protein Synonym Atrial natriuretic factor prohormone; Atrial natriuretic peptide prohormone; Atriopeptigen
Gene ID 100034201
UniProt ID P27104

Shipping and Storage

This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket